California state Senator Scott Wiener pulled his bill Thursday that sought to decriminalize a wide class of psychedelics

California (P): California state Senator Scott Wiener pulled his bill Thursday that sought to decriminalize a wide class of psychedelics in a bid to allow time for further education of some of his skeptical colleagues while sparing his Democratic ally Governor Gavin Newsom from having to sign a bill with potential political costs.

Wiener said he would reintroduce Senate Bill 519, which would remove criminal penalties for possession of drugs like magic mushrooms and LSD, next year after laying significant groundwork for the eventual passage of a bill to revolutionize the legal approach to psychoactive drugs.


Connecticut (P): Greenwich-based bioscience company B.More Inc. submitted an investigational new drug (IND) application to the FDA for the use of synthetic psilocybin in treatment of alcohol use disorder, the company announced this week. B.More, a nonprofit biopharma firm, is seeking to launch a Phase 2b trial slated to start in early 2023, to be led by Dr. Michael Bogenschutz, director of the NYU Langone Center for Psychedelic Medicine.

With a planned 226 participants, the study would be the second largest psychedelics clinical trial ever conducted if approved, according to B.More. It would assess the 24-week efficacy and safety of synthetic psilocybin (SYNP-101) in treating moderate to severe alcohol use disorder.


Oregon (P): The beginning of 2023 will be a huge step to the US’s legalized psilocybin industry! Oregon Psilocybin Services (OPS), a new section housed within the Oregon Health Authority (OHA), will begin accepting license applications January 2, 2023. Oregon’s legalization and implementation of regulations will take three years altogether—several years may seem too long for the legalized psilocybin roll out, but better late than never. This should give the department plenty of time to draft, edit, edit some more, then implement the nation’s first regulatory framework for psilocybin.

The Oregon Health Authority (OHA), Public Health Division, has released their proposed psilocybin rules. These rules are necessary to execute the Oregon Psilocybin Services Act. The proposed rules began with how the adoption of the rules can impact racial equity, fiscal and economic impact, and the cost of compliance. The proposed rules include standards for the types of licenses, types of psilocybin products, cultivation and production standards, health and safety expectations for workers and end consumers, training curriculum requirements, product testing, and more.